Stock GALENA BIOPHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Galena Biopharma Inc Nasdaq

Equities

US3632561086

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Galena Biopharma Inc
06-24 SELLAS Life Sciences Group, Inc. Announces U.S. FDA Rare Pediatric Disease Designation Granted to Sls009 for the Treatment of Pediatric Acute Lymphoblastic Leukemia CI
06-17 SELLAS Life Sciences Group, Inc. Announces Positive Recommendation from the Independent Data Monitoring Committee of the Phase 3 REGAL Trial in Acute Myeloid Leukemia CI

Chart calendar Galena Biopharma Inc

232f98454f3637f3.L0n8oW8Up7tHRP0b58ssoA86LfQEQvSM5Lr6AV2dMlw.TiGQmAFR8uIDB6t80vl_lHYOW801LZXCj--UVhupQR1JAc7sHmDF0iYxxQ~5fe48ffbdee8366a7248217091c870bc

Upcoming events on Galena Biopharma Inc

07/08/2024 Q2 2024 Earnings Release (Projected)
13/11/2024 Q3 2024 Earnings Release (Projected)
19/03/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Galena Biopharma Inc

20/06/2024 13:30 Annual General Meeting
03/06/2024 11:30 Shareholders Meeting
14/05/2024 21:05 Q1 2024 Earnings Release
28/03/2024 20:05 Q4 2023 Earnings Release
26/03/2024 12:15 Business Update Call
03/03/2024 11:00 European School of Haematology Acute Leukaemias Conference - Abstract No:6192705
03/01/2024 13:30 Business Update Call
23/11/2023 12:00 Annual General Meeting
09/11/2023 21:04 Q3 2023 Earnings Release
04/11/2023 Global Meeting of the International Gynecologic Cancer Society
27/09/2023 14:10 Cantor Global Healthcare Conference
10/08/2023 21:08 Q2 2023 Earnings Release
21/06/2023 14:30 Maxim Group Virtual Healthcare Conference - Fireside Chat
20/06/2023 13:30 Annual General Meeting
05/06/2023 14:00 American Society of Clinical Oncology Conference - Abstract No : TPS7074
30/05/2023 13:00 Business Update Call
11/05/2023 21:12 Q1 2023 Earnings Release
16/03/2023 20:11 Q4 2022 Earnings Release
31/01/2023 13:30 Investor Meeting - Key Opinion Leader:Galinpepimut-S
12/12/2022 American Society of Hematology Meeting - Abstract #: 4263

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		1,90
0,00
- 		7,60
5,07
50%		1,00
1,00
0%		0,00
13,0
-
0,00

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-17,2
-15,7
-9.7%		-17,0
-16,9
-0.39%		-25,3
-24,3
-4.19%		-42,0
-37,7
-11.17%		-37,9
-30,3
-24.83%
-37,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-19,4
-14,4
-34.79%		-16,8
-17,2
2.64%		-20,9
-23,4
10.57%		-41,3
-39,6
-4.25%		-37,3
-25,8
-44.54%
-37,4

Net income
Million USD		Released
Forecast
Spread 		-28,0
-19,4
-43.97%		-16,8
-17,3
2.41%		-20,7
-21,1
2.04%		-41,3
-39,6
-4.25%		-37,3
-29,8
-25.2%
-37,4

EPS
USD		Released
Forecast
Spread 		-10,9
-9,71
-12.52%		-2,11
-1,83
-15.3%		-1,34
-1,34
-0.19%		-2,13
-2,10
-1.55%		-1,34
-1,10
-21.82%
-0,70

Announcement Date13/03/2023/03/2131/03/2216/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		1,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
13,0
- 		0,00
13,0
- 		0,00
0,00
-
0,00


0,00


0,00







EBIT
Million USD		Released
Forecast
Spread 		-6,74
-6,77
0.56%		-8,62
-7,39
-16.66%		-7,15
-8,00
10.71%		-9,45
-7,38
-27.96%		-11,3
-8,56
-31.86%		-8,84
-9,63
8.16%		-9,36
0,70
-1443.52%		-8,18
-0,64
-1168.4%		-9,65
-10,0
3.8%
-9,50


-9,24


-9,37







Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-16,7
-6,22
-169.41%		-8,41
-7,27
-15.7%		-7,02
-8,00
12.26%		-9,12
-7,17
-27.29%		-11,1
-8,51
-30.36%		-8,84
-9,56
7.49%		-9,27
0,73
-1368.15%		-8,14
3,37
-341.39%		-9,57
-9,95
3.9%
-9,45


-9,20


-9,28







Net income
Million USD		Released
Forecast
Spread 		-16,7
-6,22
-169.41%		-8,41
-7,27
-15.7%		-7,02
-8,00
12.26%		-9,12
-7,17
-27.29%		-11,1
-8,51
-30.36%		-8,84
-9,56
7.49%		-9,27
0,73
-1368.15%		-8,14
3,37
-341.39%		-9,57
-9,95
3.9%
-9,45


-9,20


-9,28







EPS
USD		Released
Forecast
Spread 		-1,05
-0,38
-176.32%		-0,41
-0,39
-5.13%		-0,34
-0,39
12.07%		-0,43
-0,32
-34.38%		-0,47
-0,29
-62.07%		-0,31
-0,36
12.68%		-0,33
0,02
-1985.71%		-0,25
-0,03
-837.38%		-0,21
-0,16
-31.25%
-0,17


-0,17


-0,15


-0,13


-0,13

Announcement Date12/05/2211/08/2214/11/2216/03/2311/05/2310/08/2309/11/2328/03/2414/05/24-----

Upcoming sector events for Galena Biopharma Inc

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Galena Biopharma Inc

05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. SLS Stock
  4. Stock
  5. Calendar Galena Biopharma Inc